202 related articles for article (PubMed ID: 23630584)
21. Inhibition of stress-inducible kinase pathways by tumorigenic mutant p53.
Ohiro Y; Usheva A; Kobayashi S; Duffy SL; Nantz R; Gius D; Horikoshi N
Mol Cell Biol; 2003 Jan; 23(1):322-34. PubMed ID: 12482984
[TBL] [Abstract][Full Text] [Related]
22. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
23. Mutant p53 in cell adhesion and motility.
Yeudall WA; Wrighton KH; Deb S
Methods Mol Biol; 2013; 962():135-46. PubMed ID: 23150443
[TBL] [Abstract][Full Text] [Related]
24. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
[TBL] [Abstract][Full Text] [Related]
25. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.
Wang W; Takimoto R; Rastinejad F; El-Deiry WS
Mol Cell Biol; 2003 Mar; 23(6):2171-81. PubMed ID: 12612087
[TBL] [Abstract][Full Text] [Related]
26. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
27. Hedgehog/GLI signaling activates suppressor of cytokine signaling 1 (SOCS1) in epidermal and neural tumor cells.
Laner-Plamberger S; Wolff F; Kaser-Eichberger A; Swierczynski S; Hauser-Kronberger C; Frischauf AM; Eichberger T
PLoS One; 2013; 8(9):e75317. PubMed ID: 24058673
[TBL] [Abstract][Full Text] [Related]
28. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
Song H; Hollstein M; Xu Y
Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
[TBL] [Abstract][Full Text] [Related]
29. DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation.
Moiseeva O; Mallette FA; Mukhopadhyay UK; Moores A; Ferbeyre G
Mol Biol Cell; 2006 Apr; 17(4):1583-92. PubMed ID: 16436515
[TBL] [Abstract][Full Text] [Related]
30. Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells.
Kogan-Sakin I; Tabach Y; Buganim Y; Molchadsky A; Solomon H; Madar S; Kamer I; Stambolsky P; Shelly A; Goldfinger N; Valsesia-Wittmann S; Puisieux A; Zundelevich A; Gal-Yam EN; Avivi C; Barshack I; Brait M; Sidransky D; Domany E; Rotter V
Cell Death Differ; 2011 Feb; 18(2):271-81. PubMed ID: 20689556
[TBL] [Abstract][Full Text] [Related]
31. Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer.
Shakya R; Tarulli GA; Sheng L; Lokman NA; Ricciardelli C; Pishas KI; Selinger CI; Kohonen-Corish MRJ; Cooper WA; Turner AG; Neilsen PM; Callen DF
Oncogene; 2017 Aug; 36(31):4469-4480. PubMed ID: 28368395
[TBL] [Abstract][Full Text] [Related]
32. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
33. Cancer cells suppress p53 in adjacent fibroblasts.
Bar J; Feniger-Barish R; Lukashchuk N; Shaham H; Moskovits N; Goldfinger N; Simansky D; Perlman M; Papa M; Yosepovich A; Rechavi G; Rotter V; Oren M
Oncogene; 2009 Feb; 28(6):933-6. PubMed ID: 19060923
[TBL] [Abstract][Full Text] [Related]
34. Mutant p53-a potential player in shaping the tumor-stroma crosstalk.
Stein Y; Aloni-Grinstein R; Rotter V
J Mol Cell Biol; 2019 Jul; 11(7):600-604. PubMed ID: 31318969
[TBL] [Abstract][Full Text] [Related]
35. Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway.
Sun Q; Xiang RL; Yang YL; Feng K; Zhang K; Ding WY
Chin Med J (Engl); 2013 Nov; 126(21):4048-53. PubMed ID: 24229672
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor p53 and its homologue p73alpha affect cell migration.
Sablina AA; Chumakov PM; Kopnin BP
J Biol Chem; 2003 Jul; 278(30):27362-71. PubMed ID: 12750388
[TBL] [Abstract][Full Text] [Related]
37. Molecular genetic characterization of p53 mutated oropharyngeal squamous cell carcinoma cells transformed with human papillomavirus E6 and E7 oncogenes.
Oh JE; Kim JO; Shin JY; Zhang XH; Won HS; Chun SH; Jung CK; Park WS; Nam SW; Eun JW; Kang JH
Int J Oncol; 2013 Aug; 43(2):383-93. PubMed ID: 23708675
[TBL] [Abstract][Full Text] [Related]
38. p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner.
Addadi Y; Moskovits N; Granot D; Lozano G; Carmi Y; Apte RN; Neeman M; Oren M
Cancer Res; 2010 Dec; 70(23):9650-8. PubMed ID: 20952507
[TBL] [Abstract][Full Text] [Related]
39. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
40. TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73.
Liu K; Ling S; Lin WC
Mol Cell Biol; 2011 Nov; 31(22):4464-81. PubMed ID: 21930790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
